Combivir and Phenergan drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Combivir (lamivudine; zidovudine) and Phenergan (promethazine hydrochloride). Common drug interactions include anhedonia among females and emotional distress among males.

The phase IV clinical study analyzes what interactions people have when they take Combivir and Phenergan. It is created by eHealthMe based on reports of 52 people who take the same drugs from the FDA, and is updated regularly.

What is Combivir?

Combivir has active ingredients of lamivudine; zidovudine. It is often used in hiv infection. eHealthMe is studying from 15,450 Combivir users. Check the latest studies of Combivir.

What is Phenergan?

Phenergan has active ingredients of promethazine hydrochloride. It is often used in nausea. eHealthMe is studying from 25,312 Phenergan users. Check the latest studies of Phenergan.



On Jul, 30, 2026

52 people who take Combivir and Phenergan together, and have interactions are studied.

Combivir and Phenergan drug interactions.

What are the common drug interactions of Combivir and Phenergan, by gender? *:

female:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Anxiety
  3. Arthralgia (joint pain)
  4. Back pain
  5. Clavicle fracture
  6. Emotional distress
  7. Foetal exposure during pregnancy (exposing your unborn child to contraindicated in pregnancy leads birth defect)
  8. Jaw fracture
  9. Musculoskeletal chest pain (pain in chest muscle or nerve or bones)
  10. Osteopenia (a condition where bone mineral density is lower than normal)

male:

  1. Emotional distress
  2. Pain
  3. Cardiac murmur (an heart sound in valve abnormality)
  4. Chronic kidney disease
  5. Staphylococcal bacteraemia (a bacterial infection of blood)
  6. Thrombocytopenia neonatal (decrease of platelets in blood in baby less than a month)
  7. Hepatosplenomegaly neonatal (enlargement of both the liver and the spleen in neonatal)
  8. Hyperbilirubinaemia neonatal (excess of bilirubin in the blood in newborn)
  9. Portal vein thrombosis (venous thrombosis affecting the hepatic portal vein)
  10. Pulmonary hypertension (increase in blood pressure in the lung artery)

What are the common drug interactions of Combivir and Phenergan, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Chronic kidney disease
  2. Renal failure (kidney dysfunction)
  3. Death
  4. Decreased activity
  5. Fear
  6. Impaired work ability
  7. Quality of life decreased
  8. Renal injury (kidney injury)
  9. Skeletal injury (bone and supporting muscle injury)
  10. Malignant neoplasm of lacrimal duct (cancer tumour of tear duct)

30-39:

  1. Anxiety
  2. Chronic kidney disease
  3. Emotional distress
  4. Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
  5. Mobility decreased (ability to move is reduced)
  6. Pain
  7. Renal cyst (kidney cyst)
  8. Renal failure (kidney dysfunction)
  9. Renal tubular necrosis (death of kidney tubules)
  10. Atelectasis (partial or complete collapse of the lung)

40-49:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Anxiety
  3. Emotional distress
  4. Pain
  5. Renal failure (kidney dysfunction)
  6. Decreased activity
  7. Renal colic (renal pain)
  8. Azotaemia (excess of urea or other nitrogenous compounds in the blood)
  9. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  10. Hyperkalaemia (damage to or disease of the kidney)

50-59:

n/a

60+:

  1. Anaemia (lack of blood)
  2. Beta haemolytic streptococcal infection (infection with streptococcus pyogenes, a beta-haemolytic bacterium cause mild to moderately severe respiratory tract, skin, and soft tissue)
  3. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
  4. Haemoglobin decreased
  5. Influenza
  6. Nasopharyngitis (inflammation of the nasopharynx)
  7. Pleurisy (inflammation of the pleurae, which causes pain when breathing)
  8. Pneumonia
  9. Staphylococcus test positive
  10. Anhedonia (inability to experience pleasure from activities usually found enjoyable)

What are the existing conditions these people have? *

  1. Hiv Infection: 38 people, 73.08%
  2. Stress And Anxiety: 8 people, 15.38%
  3. High Blood Pressure: 6 people, 11.54%
  4. Epidural Anaesthesia: 6 people, 11.54%
  5. Drug Exposure During Pregnancy: 6 people, 11.54%
  6. Diabetes: 5 people, 9.62%
  7. Procedural Pain: 4 people, 7.69%
  8. Insomnia (sleeplessness): 4 people, 7.69%
  9. Infection: 4 people, 7.69%
  10. High Blood Cholesterol: 4 people, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Combivir and Phenergan?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Combivir and Phenergan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Combivir:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Phenergan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Combivir and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Phenergan and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on lamivudine; zidovudine and promethazine hydrochloride (the active ingredients of Combivir and Phenergan, respectively), and Combivir and Phenergan (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: